Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.
FDA Approves Semaglutide, Novo Nordisk's Once-Weekly GLP-1 for Type 2 Diabetes
Semaglutide, Novo Nordisk’s once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist for type 2 diabetes (T2D), received FDA approval Tuesday, after beating its rival in a head-to-head trial and coming to the approval process with proof of cardiovascular benefits already in hand.
CMS Finalizes Changes to Joint Replacement Bundles; Verma Promises Shift to Voluntary Models
Scaling back the Comprehensive Care for Joint Replacement model and canceling an expansion proposed under the Obama administration represents a shift in philosophy from mandatory to voluntary bundled payment models. But some say that commercial payers and employers will demand change no matter what CMS does.
Oncologists Can Save Oncology If They Take Ownership of Costs, Kolodziej Says
High chemotherapy costs are only one reason for the rising cost of cancer care. End-of-life care and hospitalizations are within an oncologist's control and must be better managed given new reimbursement structures.
FDA Action on MSK Tumor Profiling Assay Breaks Ground on Multiple Fronts
FDA on Thursday authorized a faster approval path for a next-generation sequencing assay developed at Memorial Sloan Kettering Cancer Center (MSK) that represents both a scientific and regulatory breakthrough at the agency.
What Happens When Medication Adherence Improves, but Outcomes Don't Change?
The findings, presented at the 2017 American Heart Association Scientific Sessions, suggest that a "precision medicine" approach to tailoring adherence strategies to individual patients may be needed, according to the study's lead author.
From Bacteria to Eczema: Johns Hopkins Team Studies How Inflammation Happens
For almost all adults who come into contact with Staphylococcus aureaus, the bacteria is harmless; but for a handful of people it is the cause of a debilitating, itchy red skin rash. Researchers at Johns Hopkins School of Medicine set out to learn more about this bacteria.